Global Medicated Shampoo Market Size By Type (To Dandruff, Treatment of Psoriasis), By Application (HyperMarket Sizes/SuperMarket Sizes, Convenience Stores), By Region, And Segment Forecasts, 2023 to...

The Global Medicated Shampoo Market was valued at USD 13.6 billion in 2023 and is anticipated to reach USD 22.9 billion by 2031, expanding at a CAGR of 6.8% from 2023 to 2031. This growth is primarily attributed to rising incidences of scalp-related conditions such as dandruff, psoriasis, and seborrheic dermatitis, as well as increased consumer awareness regarding personal hygiene and dermatological care. Medicated shampoos, formulated with active pharmaceutical ingredients, have witnessed growing adoption due to their efficacy in treating infections and chronic scalp disorders. Additionally, the global trend toward preventive healthcare and grooming is further bolstering demand.

Drivers

1. Rising Prevalence of Scalp and Hair Conditions

Increasing cases of dandruff, fungal infections, and dermatitis among all age groups are significantly boosting the demand for medicated shampoos. Conditions such as seborrheic dermatitis and psoriasis are leading consumers to seek targeted scalp treatments.

2. Growing Dermatological Awareness and Self-care Trends

The surge in awareness about skin and hair health, particularly through social media and digital platforms, is encouraging consumers to opt for scientifically backed products, including medicated shampoos.

3. Expansion of Distribution Channels

Wider availability of medicated shampoos across pharmacies, supermarkets, e-commerce platforms, and specialty stores has made them more accessible, especially in emerging economies.

Restraints

1. Adverse Effects and Product Sensitivities

Certain medicated shampoos contain strong active ingredients that can cause scalp irritation, dryness, or allergic reactions, deterring some consumers from frequent usage.

2. Competition from Natural and Organic Alternatives

An increasing shift toward herbal and sulfate-free alternatives may restrict the growth of synthetic medicated shampoo products, especially among health-conscious consumers.

Opportunity

1. Product Innovations and Customization

Advancements in formulation technology and growing demand for condition-specific treatments are creating opportunities for manufacturers to develop personalized medicated shampoo products.

2. Untapped Potential in Emerging Markets

Expanding middle-class populations and rising disposable incomes in regions such as Asia-Pacific, Latin America, and Africa are generating demand for affordable and effective hair treatment solutions.

Market by System Type Insights

Based on system type, the Anti-dandruff Shampoo segment held the largest market share in 2023. Formulations containing ketoconazole, zinc pyrithione, and selenium sulfide have gained popularity due to their effectiveness in addressing dandruff and fungal infections. However, the Psoriasis Treatment Shampoo segment is expected to register the fastest growth owing to rising cases of chronic scalp conditions and increased prescriptions by dermatologists.

Market by End-use Insights

In terms of end-use, the Pharmaceutical & Dermatology Clinics segment led the market in 2023, driven by growing dermatologist recommendations and prescriptions. The Retail Consumers segment, on the other hand, is expected to witness significant growth as over-the-counter (OTC) medicated shampoos become more prevalent and consumers increasingly prefer self-treatment options.

Market by Regional Insights

North America dominated the global market in 2023 due to high consumer awareness, advanced healthcare infrastructure, and a well-established dermatological industry. However, Asia-Pacific is projected to grow at the highest CAGR during the forecast period, led by rising scalp disease prevalence, growing urban populations, and increased spending on personal care in countries like China and India.

Competitive Scenario

Key players in the Global Medicated Shampoo Market include Johnson & Johnson, Procter & Gamble, Galderma, Himalaya Wellness Company, L’Oréal S.A., Unilever, Avalon Organics, Nizoral (Kramer Laboratories), Head & Shoulders (P&G), and Sebamed. These companies are leveraging product innovation, strategic partnerships, and aggressive marketing to expand their market presence.

Key Market Developments:

In 2023, Galderma launched a new dermatologically-tested anti-fungal shampoo in North America with enhanced skin sensitivity compatibility.

Johnson & Johnson expanded its Neutrogena T/Gel product line in 2024, introducing variants for color-treated hair and pediatric use.

Himalaya Wellness partnered with pharmacies across Southeast Asia in 2025 to increase retail penetration of its herbal medicated shampoo range.

Scope of Work – Global Medicated Shampoo Market

Report Metric Details

Market Size (2023) USD 13.6 billion

Projected Market Size (2031) USD 22.9 billion

CAGR (2023–2031) 6.8%

Market Segments By System Type (Anti-dandruff, Psoriasis, Anti-fungal), By End-use (Retail Consumers, Pharmaceutical & Dermatology Clinics), By Region

Growth Drivers Increasing scalp-related disorders, growing awareness of personal care, expansion of retail distribution

Opportunities Product innovation, expansion in emerging markets

FAQs

1) What is the current market size of the Global Medicated Shampoo Market?

The market was valued at USD 13.6 billion in 2023.

2) What is the major growth driver of the Global Medicated Shampoo Market?

The primary driver is the rising prevalence of scalp-related conditions and increased demand for specialized treatment products.

3) Which is the largest region during the forecast period in the Global Medicated Shampoo Market?

North America held the largest market share in 2023, while Asia-Pacific is projected to grow the fastest.

4) Which segment accounted for the largest market share in the Global Medicated Shampoo Market?

The Anti-dandruff Shampoo segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Medicated Shampoo Market?

Key players include Johnson & Johnson, Galderma, Procter & Gamble, Unilever, Himalaya Wellness, and L’Oréal S.A. among others.